Issels Integrative Immuno-Oncology August 10, 2017  

Cancer Risk May Be Identified By the Oral Microbiome


Dear Friend,

For years, the medical community has been telling us that proper oral hygiene is crucial for maintaining good overall health. Scientists are now finding that bacteria in your mouth may actually reveal your risk for different types of cancer.

What Does the Oral Microbiome Tell Us?

Here are some of the major links researchers have uncovered between mouth bacteria and cancer:

  • Fusobacterium, which causes bleeding gums, is hundreds of times more prevalent in cancerous cells than in normal cells. This bacteria can trigger colon cancer as well as accelerate growth in any existing colon tumors.
  • A study last year discovered the presence of P gingivalis, a bacteria that causes periodontal disease, in 61 percent of patients with esophageal cancer. Researchers also found that people with P gingivalis have a 60 percent higher risk of developing pancreatic cancer.
  • Researchers at the University of Buffalo conducted a study in 2015 involving more than 73,000 postmenopausal women. Results showed that women with gum disease were 14 percent more likely to develop breast cancer.

What's Next?

While conclusions have not been finalized, scientists suspect that the connection occurs when the bloodstream carries bacteria from the mouth to other organs. It's hoped that further research will enable doctors to determine cancer risk simply by the type of bacteria present in the body.

Personally Tailored Cancer Treatment Based on Your Particular Needs

All cancer cases are different, so why should all cancer treatment be the same? Visit our website to learn why Issels® is the industry leader in state-of-the-art immunotherapy methods such as cancer vaccines and NK cells that are designed for your specific situation.

Read more interesting articles on the "Issels Cancer Immunotherapy" news/blog posted every Tuesday and Thursday. Check It Out Now »


Strategic T Cells Use May Be the Key to Effective Cancer Treatment

Results showed that the two types of cells are controlled by completely different wiring. In a separate study, use of checkpoint inhibitors gave the exhausted T cells a temporary boost, but did nothing to convert them to an active state.

The researchers hope this information will help to improve CAR T-cell therapy, in which T cells are removed from a patient and retrofitted to attack tumor cells. Complete mapping of regulatory regions will provide more precise targets for treatment.

Get the Full Story!

New Liquid Biopsy Finds Cancer Markers Even Before Illness for Early Action

Pathway Genomics, a global health and research company, has developed a liquid biopsy test which can detect cancerous mutant DNA in completely healthy people. A liquid biopsy is an examination of fluid or blood drawn from the individual to find cancer cells within the blood.

The test utilizes gene sequencing to compare genetic markers within the person's blood sample. Those markers are then contrasted with genetic markers found in common cancers such as ovarian, breast, lung, and colon cancers. If there are genetic markers that match, then the test has found evidence that the patient is at risk of contracting said cancer in the future.

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.

Get the Full Story!
Interested?

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:


Google +

Contact Info:

Phone: 888-447-7357

Email: info@issels.com



Treatments | Testimonials | Contact Us